ABEO

ABEONA THERAPEUTICS INC.

ABEONA THERAPEUTICS INC. (ABEO) has 16 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jul 22, 2026.

The most active filer is Chief Financial Officer Vazzano Joseph Walter with 4 filings. Insiders have net sold $1.9M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Vishwas Seshadri
  • Employees:136
  • HQ:Cleveland, NY, US
  • IPO:1980-09-19

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.9M

reported sales (SEC code S)

Unique Insiders

8

in the rolling window

Market Cap

$363.6M

latest known value

Source
Sale$10KJul 22SEC ↗
Sale$173KJul 9SEC ↗
Sale$473KJul 9SEC ↗
Sale$84KJul 9SEC ↗
Sale$88KJul 9SEC ↗
Alland LeilaFirst filing
Sale$65KJul 2SEC ↗
Sale$104KJun 15SEC ↗
Sale$26KJun 10SEC ↗
Sale$33KJun 10SEC ↗
Sale$56KJun 10SEC ↗
Sale$209KJun 10SEC ↗
Sale$23KJun 10SEC ↗
Sale$29KJun 10SEC ↗
Seshadri VishwasFirst filing
Sale$133KJun 10SEC ↗
Seshadri VishwasFirst filing
Sale$169KJun 10SEC ↗
Alvino MarkFirst filing
Sale$35KMay 22SEC ↗
Sale$145KMay 15SEC ↗
Sale$33KMay 11SEC ↗

Related companies

ABEONA THERAPEUTICS INC. is in the Healthcare sector.